Cero Therapeutics Holdings Inc (CERO)

$0.07 -0.02 (-25.87%)
Market Cap 115,000.00
Revenue (ttm) 0.00
Net Income (ttm) -8.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 7,271,200
Avg Vol 2,775,432
Day's Range N/A - N/A
Shares Out 1.21M
Stochastic %K 0%
Beta 0.41
Analysts Strong Sell
Price Target $22.50

Company Profile

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.

Industry: Biotechnology
Sector: Healthcare
Phone: 650 407 2376
Address:
201 Haskins Way, Suite 230, South San Francisco, United States
Ceri78
Ceri78 Jun. 4 at 7:20 PM
$CERO so someone invested 50$ by mistake and it’s up 35% today 🤣
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jun. 4 at 1:34 PM
$MDCX : Tiny $18M Market Cap Targeting Multi Billion Dollar Markets!🚨 Medicus Pharma is quietly building a biotech pipeline focused on massive unmet markets in skin cancer and prostate/urology treatments through its proprietary SkinJect and Teverelix programs. Highlights: 🔥 Estimated cash runway now 24+ months 🔥 Positive Phase 2 SkinJect data showed registrational-grade clearance rates 🔥 FDA-cleared advancement for Teverelix Phase 2b study 🔥 Filed Orphan Drug application for SkinJect in Gorlin Syndrome Upcoming Catalysts: ✔️ More SkinJect clinical data ✔️ FDA/regulatory milestones ✔️ Potential partnerships/licensing deals ✔️ Teverelix Phase 2b progression Despite having a market cap of only around $18M, MDCX is pursuing potential multi billion dollar opportunities in markets projected to exceed $12B combined, including skin cancer, which impacts more than 5 million Americans each year. Communicated Disclaimer: http://stockresearchtoday.com/mdcx/ Sector peers: $CERO $MCRB $TCON $ABEO
0 · Reply
Gg2233444
Gg2233444 Jun. 3 at 11:36 AM
$CERO is there any hope?
2 · Reply
Kdd919
Kdd919 Jun. 1 at 7:54 PM
$CERO BK
0 · Reply
Ceri78
Ceri78 May. 26 at 6:39 PM
$CERO zero zero zero!!!
0 · Reply
Radar76
Radar76 May. 26 at 6:02 PM
$CERO 🤔🤔🤔 ?!! . . .
1 · Reply
BPler
BPler May. 26 at 1:40 PM
$CERO Because nobody posted it here, from 11th may: https://cero.bio/press-release?storyId=5792037826469078
1 · Reply
Kdd919
Kdd919 May. 20 at 5:26 PM
$CERO Next stop BK
0 · Reply
Gg2233444
Gg2233444 May. 19 at 6:23 PM
$CERO
0 · Reply
Dragon3505
Dragon3505 May. 19 at 4:53 PM
$CERO Is the CEO in jail already?
0 · Reply
Latest News on CERO
No data available.
Ceri78
Ceri78 Jun. 4 at 7:20 PM
$CERO so someone invested 50$ by mistake and it’s up 35% today 🤣
0 · Reply
TheRealShortSqueezy
TheRealShortSqueezy Jun. 4 at 1:34 PM
$MDCX : Tiny $18M Market Cap Targeting Multi Billion Dollar Markets!🚨 Medicus Pharma is quietly building a biotech pipeline focused on massive unmet markets in skin cancer and prostate/urology treatments through its proprietary SkinJect and Teverelix programs. Highlights: 🔥 Estimated cash runway now 24+ months 🔥 Positive Phase 2 SkinJect data showed registrational-grade clearance rates 🔥 FDA-cleared advancement for Teverelix Phase 2b study 🔥 Filed Orphan Drug application for SkinJect in Gorlin Syndrome Upcoming Catalysts: ✔️ More SkinJect clinical data ✔️ FDA/regulatory milestones ✔️ Potential partnerships/licensing deals ✔️ Teverelix Phase 2b progression Despite having a market cap of only around $18M, MDCX is pursuing potential multi billion dollar opportunities in markets projected to exceed $12B combined, including skin cancer, which impacts more than 5 million Americans each year. Communicated Disclaimer: http://stockresearchtoday.com/mdcx/ Sector peers: $CERO $MCRB $TCON $ABEO
0 · Reply
Gg2233444
Gg2233444 Jun. 3 at 11:36 AM
$CERO is there any hope?
2 · Reply
Kdd919
Kdd919 Jun. 1 at 7:54 PM
$CERO BK
0 · Reply
Ceri78
Ceri78 May. 26 at 6:39 PM
$CERO zero zero zero!!!
0 · Reply
Radar76
Radar76 May. 26 at 6:02 PM
$CERO 🤔🤔🤔 ?!! . . .
1 · Reply
BPler
BPler May. 26 at 1:40 PM
$CERO Because nobody posted it here, from 11th may: https://cero.bio/press-release?storyId=5792037826469078
1 · Reply
Kdd919
Kdd919 May. 20 at 5:26 PM
$CERO Next stop BK
0 · Reply
Gg2233444
Gg2233444 May. 19 at 6:23 PM
$CERO
0 · Reply
Dragon3505
Dragon3505 May. 19 at 4:53 PM
$CERO Is the CEO in jail already?
0 · Reply
WolfpackOfOne
WolfpackOfOne May. 14 at 7:43 PM
$CERO back in with 60k at .027. Lost some on the first round. Steady trial progress. A buyout would be nice.
0 · Reply
Staunker
Staunker May. 11 at 7:27 PM
$CERO I still believe that this could be a winner. so far the trials have been positive. long ways to go yet but the potential is there.
1 · Reply
rockysat111
rockysat111 May. 6 at 8:25 PM
$CERO from April 27th CERo Therapeutics Raises Capital via Convertible Note Financing
0 · Reply
Ceri78
Ceri78 May. 4 at 5:10 PM
$CERO this is the end…
0 · Reply
Radar76
Radar76 May. 1 at 4:08 PM
$CERO I don't know until what time then wake up.. or this a slow death ? . . . .
0 · Reply
StocktwitsAragorn
StocktwitsAragorn Apr. 29 at 8:24 PM
$CERO Share Structure Market Cap Market Cap 1,284,765 04/28/2026 Authorized Shares Unlimited 04/28/2026 Outstanding Shares 41,876,315 04/28/2026 Restricted 20,313 04/28/2026 Unrestricted 41,856,002 04/28/2026 Held at DTC 41,854,454 04/28/2026 Float Float 29,912,798 11/21/2025
0 · Reply
Gg2233444
Gg2233444 Apr. 28 at 8:56 PM
$CERO it’s the year 2030… CERO is trading at $150 a share after having a major breakthrough for cancer research. We are all retired and living our best life. Speaking this into existence.
0 · Reply
BPler
BPler Apr. 23 at 6:31 PM
$CERO The value lost on the chart is insane, Insider should put their own money into it.
0 · Reply
Ceri78
Ceri78 Apr. 21 at 7:37 PM
$CERO shareholder phagocitator $-cells
0 · Reply
Gg2233444
Gg2233444 Apr. 17 at 2:13 PM
$CERO wtf
0 · Reply
gapureau
gapureau Apr. 10 at 2:46 PM
$MOBQ 95% revenue collapse in 2025 and otherwise pretty terrible 10-K. That perfectly explains almost double in SP in past week. Gotta Love OTC stocks that don't have to worry about NASDAQ delisting. Some management choose to stay on this market allowing a profitable company to fly under the radar like $RHCO. Then there is total mismanagement (either on purpose or thru stupidity), like $ILLR, $CERO, $DMN If you're going to trade penny stocks, you really should use some of these disasters as study material to learn some of the many ways investors can be used and abused.. Multiple Reverse Splits, Below market price financing deals, etc.!!! GLTA
1 · Reply
upsell
upsell Apr. 1 at 4:50 AM
$CERO https://www.stocktitan.net/news/CERO/ce-ro-therapeutics-doses-second-patient-in-cohort-2-of-phase-1-cer-eqvmtxpfk96s.html
0 · Reply